Results
93
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
93 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
KEBNI B | SEK 1.51 | 0.4% | 0.3% | SEK 408.4m | SEK 2.20 | PS4.4x | E90.4% | n/a | Tech | ||
CALTX | SEK 206.20 | -0.1% | 120.1% | SEK 11.1b | SEK 221.25 | PS8.5x | E52.9% | n/a | Pharmaceuticals & Biotech | ||
YUBICO | SEK 268.00 | 1.5% | 167.5% | SEK 23.1b | SEK 267.50 | PE139.4x | E43.8% | n/a | Software | ||
YIELD | SEK 2.37 | -8.5% | -67.3% | SEK 135.8m | SEK 9.00 | PB1.6x | E103.4% | n/a | Diversified Financials | ||
MAGLE | SEK 43.40 | -2.7% | 24.0% | SEK 468.7m | SEK 50.00 | PE60.9x | E72.2% | n/a | Pharmaceuticals & Biotech | ||
CTT | SEK 286.00 | -7.1% | 34.3% | SEK 3.6b | n/a | PE35.2x | E24.8% | 1.9% | Capital Goods | ||
SILEON | SEK 0.48 | -5.9% | -89.3% | SEK 24.3m | n/a | PB1.6x | E109.3% | n/a | Software | ||
BIOA B | SEK 234.00 | 1.4% | -18.6% | SEK 20.7b | SEK 368.40 | PS82x | E50.9% | 0% | Pharmaceuticals & Biotech | ||
EDYOU | SEK 0.96 | 116.5% | 31.5% | SEK 35.8m | n/a | PS1.1x | E63.1% | n/a | Media | ||
BIOVIC B | SEK 2.65 | -0.9% | -59.7% | SEK 222.3m | SEK 7.90 | PS30.5x | E73.8% | n/a | Pharmaceuticals & Biotech | ||
INCOAX | SEK 2.30 | -6.9% | -21.8% | SEK 248.8m | SEK 3.65 | PS2.6x | E104.9% | n/a | Tech | ||
ORGC | SEK 3.55 | -11.0% | -24.3% | SEK 348.3m | SEK 3.00 | PS2.5x | E109.0% | n/a | Materials | ||
CRAD B | SEK 45.20 | -7.5% | 59.2% | SEK 1.5b | SEK 57.00 | PE28.4x | E33.9% | n/a | Healthcare | ||
FLEXQ | SEK 10.10 | -1.5% | -62.3% | SEK 135.4m | SEK 25.00 | PS1.1x | E111.9% | n/a | Capital Goods | ||
ORT B | SEK 9.08 | -2.6% | 21.4% | SEK 336.7m | SEK 19.50 | PS5.4x | E91.6% | n/a | Healthcare | ||
CTM | SEK 6.69 | 7.4% | -71.5% | SEK 506.1m | SEK 29.70 | PB0.3x | E115.4% | 0% | Media | ||
TRUE B | SEK 33.44 | -5.5% | -22.1% | SEK 11.6b | SEK 54.83 | PE24.2x | E21.5% | 1.2% | Software | ||
4C | SEK 18.50 | -5.1% | -31.5% | SEK 649.9m | SEK 22.00 | PS2.2x | E108.1% | n/a | Software | ||
KLAR | SEK 0.38 | 17.7% | -39.8% | SEK 49.2m | SEK 1.00 | PB1.7x | E61.3% | n/a | Pharmaceuticals & Biotech | ||
EQT | SEK 336.60 | 3.4% | 34.7% | SEK 398.3b | SEK 365.05 | PE112.5x | E56.6% | 1.1% | Diversified Financials | ||
SENZA | SEK 7.20 | 1.4% | -32.1% | SEK 212.4m | SEK 16.50 | PS4.1x | E67.8% | n/a | Pharmaceuticals & Biotech | ||
MIDS | SEK 1.29 | 5.6% | -47.3% | SEK 270.5m | SEK 2.80 | PS4.2x | E89.9% | n/a | Semiconductors | ||
FNOX | SEK 65.04 | -0.03% | 0.9% | SEK 39.7b | SEK 73.78 | PE61x | E22.6% | 0.3% | Software | ||
NIUTEC | SEK 6.64 | 4.4% | -42.3% | SEK 134.0m | SEK 9.50 | PB1.6x | E94.1% | n/a | Capital Goods |